In addition, we found that low <i>DHRS4-AS1</i> expression was significantly associated with a high tumor node metastasis stage, lymph node metastasis, advanced pathological grade and poor prognosis.
Taken together, our findings identify the role of <i>DHRS4-AS1</i> as a tumor inhibitor in ccRCC for the first time, demonstrating that <i>DHRS4-AS1</i> is a potential prognostic biomarker that could potentially be applied in ccRCC therapy.
Taken together, our findings identify the role of <i>DHRS4-AS1</i> as a tumor inhibitor in ccRCC for the first time, demonstrating that <i>DHRS4-AS1</i> is a potential prognostic biomarker that could potentially be applied in ccRCC therapy.
These data indicate that <i>DHRS4-AS1</i> functions by preventing the proliferation and invasion, inhibiting the cell cycle progression and promoting the apoptosis of ccRCC cells.
Expression of a novel alternatively spliced variant of NADP(H)-dependent retinol dehydrogenase/reductase with deletion of exon 3 in cervical squamous carcinoma.